{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:08Z","timestamp":1707524528068},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,19]]},"DOI":"10.7759\/cureus.24283","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T16:31:21Z","timestamp":1650385881000},"source":"Crossref","is-referenced-by-count":1,"title":["Male Breast Metastasis: A Case of Treatment-Emergent Neuroendocrine Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Rita","family":"Sismeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida","family":"Brito Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Negr\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Jonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3309","article-title":"Aggressive variants of castration-resistant prostate cancer","volume":"20","author":"Beltran H","year":"2014","unstructured":"Beltran H, Tomlins S, Aparicio A, et al.. Aggressive variants of castration-resistant prostate cancer. Clin Cancer Res. 2014, 20:2846-50. 10.1158\/1078-0432.CCR-13-3309","journal-title":"Clin Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2014.0073","article-title":"Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes","volume":"12","author":"Aggarwal R","year":"2014","unstructured":"Aggarwal R, Zhang T, Small EJ, Armstrong AJ. Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes. J Natl Compr Canc Netw. 2014, 12:719-26. 10.6004\/jnccn.2014.0073","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.3553","article-title":"Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis\u2014a systematic review and pooled analysis","volume":"32","author":"Wang HT","year":"2014","unstructured":"Wang HT, Yao YH, Li BG, Tang Y, Chang JW, Zhang J. Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis\u2014a systematic review and pooled analysis. J Clin Oncol. 2014, 32:3383-90. 10.1200\/JCO.2013.54.3553","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2012.4","article-title":"A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008","volume":"15","author":"Marcus DM","year":"2012","unstructured":"Marcus DM, Goodman M, Jani AB, Osunkoya AO, Rossi PJ. A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008. Prostate Cancer Prostatic Dis. 2012, 15:283-8. 10.1038\/pcan.2012.4","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87441-2","article-title":"Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients","volume":"11","author":"Bhagirath D","year":"2021","unstructured":"Bhagirath D, Liston M, Akoto T, Lui B, Bensing BA, Sharma A, Saini S. Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients. Sci Rep. 2021, 11:8279. 10.1038\/s41598-021-87441-2","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.792","article-title":"Specific organ metastases and survival in small cell lung cancer","volume":"4","author":"Nakazawa K","year":"2012","unstructured":"Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H, Hizawa N. Specific organ metastases and survival in small cell lung cancer. Oncol Lett. 2012, 4:617-20. 10.3892\/ol.2012.792","journal-title":"Oncol Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000442045","article-title":"Prostate cancer: cases of rare presentation and rare metastasis","volume":"8","author":"Mandaliya H","year":"2015","unstructured":"Mandaliya H, Sung J, Hill J, Samali R, George M. Prostate cancer: cases of rare presentation and rare metastasis. Case Rep Oncol. 2015, 8:526-9. 10.1159\/000442045","journal-title":"Case Rep Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170197","article-title":"Breast metastases from extramammary malignancies: multimodality imaging aspects","volume":"90","author":"Bitencourt AG","year":"2017","unstructured":"Bitencourt AG, Gama RR, Graziano L, et al.. Breast metastases from extramammary malignancies: multimodality imaging aspects. Br J Radiol. 2017, 90:20170197. 10.1259\/bjr.20170197","journal-title":"Br J Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(00)80084-9","article-title":"Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?","volume":"196","author":"Reis-Filho JS","year":"2000","unstructured":"Reis-Filho JS, Carrilho C, Valenti C, Leit\u0103o D, Ribeiro CA, Ribeiro SG, Schmitt FC. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?. Pathol Res Pract. 2000, 196:835-40. 10.1016\/S0344-0338(00)80084-9","journal-title":"Pathol Res Pract"},{"key":"ref10","article-title":"Neuroendocrine differentiation of prostate cancer: a review","volume":"2","author":"Parimi V","year":"2014","unstructured":"Parimi V, Goyal R, Poropatich K, Yang XJ. Neuroendocrine differentiation of prostate cancer: a review. Am J Clin Exp Urol. 2014, 2:273-85.","journal-title":"Am J Clin Exp Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87450-male-breast-metastasis-a-case-of-treatment-emergent-neuroendocrine-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:02Z","timestamp":1707507422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87450-male-breast-metastasis-a-case-of-treatment-emergent-neuroendocrine-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.24283","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,19]]}}}